Original Research
Sze-jung Wu, PhD
Qinli Ma, PhD
Patricia Martin, RN, BSN
Andrea DeVries, PhD
Value-based centers of excellence programs offer an advance over programs that focus only on cost or quality alone in the ability to identify facilities with lower costs and equal or better quality outcomes. Value designation offers patients transparency for selecting care providers.
MediMedia Research Survey
Respondents to the survey of medical directors and chief medical directors officers rated their organization’s commitment to value-based care as high, a development that will mean grappling with the cost implications of clinical policies and practices. A third said a large percentage (41% or higher) of their job concerns the financial performance of their organization.

The brouhaha generated by Turing Pharmaceuticals and Valeant Pharmaceuticals this year because they jacked up some older medicines they’d purchased to head-line grabbing heights may have provided cover for the rest of the industry, according to Leonard Schleifer, MD, the head of Regeneron Pharmac

Legislation & Regulation
Richard Mark Kirkner
Because hospital spending makes up the largest piece of U.S. health care spending—32%, according to data from CMS—any judicial rulings or legislative move to curb a hospital’s market dominance are key to controlling overall health care costs. The FTC is stepping in.

The American Medical Association (AMA) is being inundated by tweets from doctors furious that the organization supports the nomination of Republican House Budget Committee Chairman Tom Price for secretary of the Health and Human Services Department, according to STAT.

Zachary Hafner

Zachary Hafner
Advisory Board

The transformation of health care is fundamentally altering the environment in which health systems function, placing the CMO squarely at the center of a new reality where concepts like value, population health management, and outcomes-based payment are becoming key drivers of success.

By a 392 to 26 vote, the House of Representatives passed the 21st Century Cures Act, which would speed FDA approval for drugs and medical devices and allow the agency to include real world evidence in the approval process.

Medical Director Profiles
Howard Wolinsky

Neal Kaufman, MD

“My job as CMO is to make sure we’re keeping the patient at the center—that our products make sense to them and to clinicians,” he says. Canary’s programs come from protocols that have been vetted by scientists, clinicians, and patients over many years, if not decades.
Medical Director Profiles
Howard Wolinsky

Steve Miller, MD

“Some days I’m out supporting our sales people and trying to acquire new business. Some days I’m with our legal teams trying to help them decipher new regulations. Some days I am with our supply team group negotiating with the pharmaceutical companies.”